---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-018306"
form_type: "8-K"
ticker: "XRN"
cik: "0001533615"
company_name: "Chiron Real Estate Inc."
filed_at: "2025-02-27T23:59:59+00:00"
generated_at: "2026-05-26T01:42:03.929992+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# GMRE Q4 AFFO $0.22/unit flat YoY; JV with Heitman; 2025 guidance $0.89-$0.93

## Summary
- Q4 2024 net income $1.4M ($0.02/diluted) vs net loss $0.8M (-$0.01) in Q4 2023; full-year net income $0.8M ($0.01) vs $14.8M ($0.23).
- Q4 AFFO $15.8M ($0.22/unit) vs $15.9M ($0.23) prior year; full-year AFFO $63.4M ($0.89) vs $64.3M ($0.91).
- Acquired $80.3M of net-lease medical assets in 2024 at 8.0% cap rate; entered JV with Heitman (12.5% stake) and contributed two assets for $35.2M.
- CEO Jeff Busch to step down by June 30, 2025; $3.2M severance charge recorded in Q4; search for successor underway.
- Full-year 2025 AFFO guidance introduced at $0.89-$0.93 per share/unit; Q1 2025 common dividend maintained at $0.21/share.

## SEC filing metadata
- accession: 0001104659-25-018306
- form_type: 8-K
- ticker: XRN
- cik: 0001533615
- company_name: Chiron Real Estate Inc.
- filed_at: 2025-02-27T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533615/000110465925018306/0001104659-25-018306-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533615/000110465925018306/tm257811d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-018306
- JSON: https://secwatch.observer/filing/0001104659-25-018306.json
- Plain text: https://secwatch.observer/filing/0001104659-25-018306.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.